Jordan Davisson Cook

Counsel

Orange County
jordan.cook@lw.com
+1.714.755.8238

PRACTICES

  • Complex Commercial Litigation
  • Litigation & Trial
  • Mergers & Acquisitions Litigation
  • Securities Litigation & Professional Liability
  • White Collar Defense & Investigations

INDUSTRIES

  • Financial Institutions
  • Healthcare & Life Sciences

BAR QUALIFICATIONS

  • California

EDUCATION

  • JD, University of Southern California Gould School of Law, 2013
    Managing Editor, Southern California Interdisciplinary Law Journal
  • BA in Biology, The University of Texas at Austin, 2008

LANGUAGES SPOKEN

  • English

PROFILE

Jordan Cook represents a variety of clients on complex commercial litigation, with an emphasis on securities litigation, complex business disputes, professional liability, activism, and class action litigation.

Jordan assists companies, management, and boards of directors in connection with:

  • Securities class action suits
  • Shareholder derivative litigation
  • Books-and-records demands
  • M&A, activism, and Delaware corporate governance
  • SEC enforcement matters

Jordan is on the Board of the Federal Bar Association (OC Chapter) and serves on the Training and Career Enhancement Committee. She has previously served on the Associates and Technology Committees. Prior to joining Latham, Jordan worked at another AmLaw50 firm representing clients in complex commercial litigation matters. 

EXPERIENCE

Jordan’s recent cases include representing:

  • Puma Biotechnology: At trial, defeated more than 95 percent of plaintiffs’ claimed damages in rare Section 10(b) securities class action to go to jury verdict, named by the Daily Journal as one of the Top Verdicts of 2019 (C.D. Cal.)
  • GoodRx – Won final dismissal of securities class action challenging company’s IPO disclosures following major competitor’s entry into prescription-drug pricing market (C.D. Cal.)
  • Alteryx – Won final first-round dismissal of securities class action against technology company following withdrawal of guidance in the early days of the pandemic (C.D. Cal.)
  • Desktop Metal, Inc. – Won dismissal of securities fraud claims against 3D printing company based on whistleblower investigation
  • Prometheus Biosciences in its US$11 billion acquisition by Merck (D. Del., S.D.N.Y. 2023)
  • Cerner Corp. in US$28.3 billion acquisition by Oracle (E.D.N.Y. 2022), named among the Deal Awards Most Outstanding Deal of the Year in 2022